[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GR3037049T3 - New indications for the use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses - Google Patents

New indications for the use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses

Info

Publication number
GR3037049T3
GR3037049T3 GR20010401921T GR20010401921T GR3037049T3 GR 3037049 T3 GR3037049 T3 GR 3037049T3 GR 20010401921 T GR20010401921 T GR 20010401921T GR 20010401921 T GR20010401921 T GR 20010401921T GR 3037049 T3 GR3037049 T3 GR 3037049T3
Authority
GR
Greece
Prior art keywords
parapox
viruses
multipotent
attenuated
medicaments
Prior art date
Application number
GR20010401921T
Other languages
English (en)
Inventor
Anton Prof Dr Med Vet Dr Mayr
Original Assignee
Anton Prof Dr Med Vet Dr Mayr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anton Prof Dr Med Vet Dr Mayr filed Critical Anton Prof Dr Med Vet Dr Mayr
Publication of GR3037049T3 publication Critical patent/GR3037049T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24211—Parapoxvirus, e.g. Orf virus
    • C12N2710/24232—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Control Of El Displays (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GR20010401921T 1996-04-15 2001-10-30 New indications for the use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses GR3037049T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19614810 1996-04-15
PCT/DE1997/000761 WO1997038724A1 (de) 1996-04-15 1997-04-14 Neue indikationen für die verwendung von multipotenten paramunitätsinducern aus attenuierten, nicht-immunogenen pockenviren oder parapockenviren als arzneimittel

Publications (1)

Publication Number Publication Date
GR3037049T3 true GR3037049T3 (en) 2002-01-31

Family

ID=7791302

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010401921T GR3037049T3 (en) 1996-04-15 2001-10-30 New indications for the use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses

Country Status (20)

Country Link
US (1) US6162600A (el)
EP (1) EP0885013B1 (el)
JP (1) JP3568208B2 (el)
KR (1) KR100302994B1 (el)
CN (1) CN1165343C (el)
AT (1) ATE203678T1 (el)
AU (1) AU706729B2 (el)
BR (1) BR9708679A (el)
CA (1) CA2251690C (el)
DE (2) DE59704194D1 (el)
DK (1) DK0885013T3 (el)
ES (1) ES2125846T3 (el)
GR (1) GR3037049T3 (el)
HU (1) HU224308B1 (el)
NO (1) NO322176B1 (el)
NZ (1) NZ332243A (el)
PL (1) PL329353A1 (el)
PT (1) PT885013E (el)
SI (1) SI0885013T1 (el)
WO (1) WO1997038724A1 (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK362003A3 (en) * 2000-07-11 2003-07-01 Bayer Ag Use of strains of the Parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals
NZ523535A (en) * 2000-07-11 2004-12-24 Bayer Ag Use of strains of the Parapoxvirus ovis against organ fibroses
DE10122233A1 (de) * 2000-07-11 2002-01-24 Bayer Ag Verwendung von Stämmen des Parapoxvirus ovis gegen Organfibrosen
US6844000B2 (en) 2001-12-07 2005-01-18 Bayer Pharmaceuticals Corporation Use of Parapox B2L protein to treat cancer and modify immune responses
DE602005016552D1 (de) * 2004-07-13 2009-10-22 Aicuris Gmbh & Co Kg Parapocken-viren in kombination mit anderen antiviralen mitteln zur behandlung von hiv/aids
DE102004045758A1 (de) * 2004-09-21 2006-04-06 Toximed Gmbh Pharmazeutischer Wirkstoff gegen das HIV-Syndrom
DE102005027956B4 (de) * 2005-06-16 2009-10-22 Mayr, Anton, Prof. Dr. Dr. h.c. mult. Hochattenuierte Poxvirusstämme, Verfahren zu ihrer Herstellung und deren Verwendung als Paramunitätsinducer oder zur Herstellung von Vektor-Vakzinen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3504940C2 (de) * 1984-02-17 1997-11-06 Bayer Ag Multipotente Paramunitätsmediatoren, Verfahren zu ihrer Herstellung und diese Mediatoren enthaltende Arzneimittel
US6290962B1 (en) * 1992-11-03 2001-09-18 Oravax, Inc. Urease-based vaccine and treatment for helicobacter infection
DE4405841C1 (de) * 1994-02-23 1995-01-05 Mayr Anton Prof Dr Med Vet Dr Multipotente Paramunitätsinducer auf der Basis von Kombinationen von Pockenviruskomponenten, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
ES2125846T3 (es) 2001-12-16
NO984782D0 (no) 1998-10-14
KR20000005479A (ko) 2000-01-25
CN1165343C (zh) 2004-09-08
JP3568208B2 (ja) 2004-09-22
CA2251690A1 (en) 1997-10-23
ES2125846T1 (es) 1999-03-16
CA2251690C (en) 2005-11-08
DE59704194D1 (de) 2001-09-06
PL329353A1 (en) 1999-03-29
NZ332243A (en) 2000-10-27
ATE203678T1 (de) 2001-08-15
HUP9901299A3 (en) 2000-03-28
DE19780300D2 (de) 1999-06-17
PT885013E (pt) 2002-01-30
WO1997038724A1 (de) 1997-10-23
HU224308B1 (hu) 2005-07-28
KR100302994B1 (ko) 2001-11-30
SI0885013T1 (el) 2001-12-31
JP2000501114A (ja) 2000-02-02
DK0885013T3 (da) 2001-11-05
NO322176B1 (no) 2006-08-21
NO984782L (no) 1998-12-15
HUP9901299A2 (hu) 1999-07-28
US6162600A (en) 2000-12-19
AU2885897A (en) 1997-11-07
BR9708679A (pt) 2000-01-04
CN1215996A (zh) 1999-05-05
EP0885013A1 (de) 1998-12-23
EP0885013B1 (de) 2001-08-01
AU706729B2 (en) 1999-06-24

Similar Documents

Publication Publication Date Title
EP0835133A4 (en) RECOMBINANT COMPOSITIONS AND COMBINED COMPOSITIONS OF RABIES AND SMALLPOX VIRUSES, AND USES THEREOF
ES2140565T3 (es) Nuevos derivados de pirazina-carboxamida, su preparacion y su utilizacion en medicamentos.
GR76810B (el)
NZ511020A (en) Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
GR862201B (en) Polypeptides and antibodies characteristic of papillomavirus and their application to in vitro diagnosis the prevention and the fight against the infections by the papillomavirus
GR3037049T3 (en) New indications for the use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses
MX9806082A (es) Preparacion farmaceutica combinada de analogos de lhrh y antiestrogenos para el tratamiento de trastornos ginecologicos.
ZA855224B (en) Pyrrol-1-ylphenyldihydropyridazinones,their preparation and their use
ZA923935B (en) New 2-amino-5-cyano-1,4-dihydropyridines,processes for their preparation and their use in medicaments
DE3478397D1 (en) Pyrethroid-containing pharmaceutical compositions
JPS6455182A (en) Human papilloma virus of type 41, dna thereof and protein coded thereby
ES2013025A6 (es) Un metodo para preparar 24r-escimnol.
DE3469020D1 (en) Diarylindane-1,3-diones, their preparation and use
EP0960216A4 (en) TREATMENT OF HIV INFECTION BY HINDERING THE INTERACTION OF TOPOISOMERASE HOST WITH HIV GAG AND IT
MD916G2 (ro) Unguent pentru tratamentul afecţiunilor dentare
WO1998044913A3 (en) Compositions containing mkc-442 in combination with other antiviral agents
JPS5545618A (en) Thermal treatment of fraction containing glycoprotein which accelerates differentiation and proliferation of human granulocyte
Confavreux et al. Trends in European Multiple Sclerosis Research
JPS53127241A (en) Information processor
IT8844210A0 (it) Sistema per la riduzione della dispersione, per la conservazione e l'uniforme distribuzione del calore nel pentolame da cucina
RO99844B1 (ro) Medicament pentru tratamentul gripei si virozelor respiratorii
JPS5318786A (en) Preparation of germ-free culture medium
GR1002968B (el) Φαρμακευτικο παρασκευασμα βασιζομενο σε εναιωρημα εμβρυικων κυτταρων με ανοσοδιορθωτικη δραση και μεθοδος θεραπειας ζαχαρωδους διαβητη με τη χρηση αυτου του παρασκευασματος.
UA29639A (uk) Протипухлинний засіб
ZA79295B (en) Catalyst,its preparation and use in the polymerisation of butadiene

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees